Development of Multiple Myeloma in a Patient with Chronic Myeloid Leukemia While on Treatment with Imatinib Mesylate for 65 Months

Author:

Michael Michalis1,Antoniades Marios1,Lemesiou Elena1,Papaminas Nicandros1,Melanthiou Freiderikh1

Affiliation:

1. Haematology Department of Nicosia General Hospital, Nicosia, Cyprus

Abstract

Abstract The simultaneous occurrence of multiple myeloma (MM) and chronic myeloid leukemia (CML) is an extremely rare event that has been reported in only eight cases in the literature. We report here on only the third case of the development of MM in a patient with CML on treatment with imatinib mesylate, and to our knowledge, this is the first case in a patient who received imatinib as first-line treatment.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Reference17 articles.

1. Multiple myeloma preceding the development of chronic myelogenous leukemia;Nitta;Int J Hematol,1999

2. Multiple myeloma superimposed on chronic myelocytic leukemia;Derghazarian;Can Med Assoc J,1974

3. Light chain disease (hypogammaglobulinemia and Bence-Jones proteinurea) and sideroblastic anemia-preleukemic chronic granulocytic leukemia;MacSween;Can Med Assoc J,1972

4. Multiple myeloma and chronic myelogenous leukemia—a case report with literature review;Klenn;Yonsei Med J,1993

5. Coexistance of multiple myeloma and chronic myelogenous leukemia;Tanaka;Int J Hematol,1999

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3